Europe Respiratory Diagnostics Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2022 –2029 |
Market Size (Base Year) |
USD 1.92 Billion |
Market Size (Forecast Year) |
USD 3.40 Billion |
CAGR |
|
Major Markets Players |
欧洲呼吸诊断市场,按产品与服务(仪器与设备、分析与试剂、服务和软件)、检测类型(传统诊断检测、机械检测、影像检测和分子诊断检测)、疾病(慢性阻塞性肺病 (COPD)、肺癌、哮喘、肺结核、支气管炎、肺纤维化和其他疾病)、最终用户(医院/临床实验室、医生办公室、参考实验室和其他最终用户)、分销渠道(直接招标、零售销售和其他)划分 – 行业趋势和预测至 2029 年
欧洲呼吸诊断市场分析及规模
预计欧洲呼吸诊断市场在预测期内将出现显着增长。全球呼吸诊断市场一直走在健康的增长道路上。呼吸诊断是治疗创新领域的重要组成部分。呼吸系统疾病的患病率不断上升,人们对准确的疾病诊断产生了重大关注,从而为呼吸诊断市场的增长铺平了道路。
Data Bridge Market Research 分析了 2022-2029 年预测期内欧洲呼吸诊断市场的增长率。在上述预测期内,欧洲呼吸诊断市场的预期复合年增长率趋于 7.40% 左右。2021 年市场价值为 19.2 亿美元,到 2029 年将增长至 34 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
市场定义
呼吸诊断在医疗技术领域发挥着重要作用。它需要使用各种机械、成像和分子诊断测试对各种呼吸系统疾病(例如支气管炎、哮喘、慢性阻塞性肺病和肺纤维化等)进行临床评估。其中包括肺量测定、计算机断层扫描、血氧测定、经皮二氧化碳监测、胸部 X 光、鼻吸气压力 (SNIP) 和其他类型的呼吸诊断。呼吸诊断测试中的各种技术进步为市场增长铺平了道路,其中包括人工智能的融入和物联网 (IoT) 的使用等。
欧洲呼吸诊断市场范围和细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) |
Countries Covered |
U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe |
Market Players Covered |
BD (U.S.), COSMED srl (Italy), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), MGC Diagnostics Corporation (U.S.), Masimo (U.S.), bioMérieux SA (France), Carestream Health (U.S.), VYAIRE (U.S.), Seegene Inc.(South Korea) and ResMed (U.S.) |
Market Opportunities |
|
Europe Respiratory Diagnostics Market Dynamics
Drivers
- Growing Rate of Diseases
The rising prevalence of tuberculosis and lung cancer are driving the market growth at a fast pace. In 2020, many more people died from TB, with far fewer people being diagnosed and treated or provided with TB preventive treatment compared with 2019, and overall spending on essential TB services falling.
- Higher Demand of Hospitals
The rising demand of hospitals increase the market growth rapidly. Most respiratory disease diagnostics are majorly carried out in hospitals as they are very complex and it requires technologically advanced products and thus this is driving the market for hospital/clinical laboratories.
Opportunities
- Increased Geriatric Population
The rising number of elderly population and associated comorbid conditions such as cough issues, deteriorating respiratory conditions, community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease and non-pneumonic respiratory tract infection tend to create opportunities of Europe respiratory diagnostics market.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these diagnostic techniques could curb the growth of the Europe respiratory diagnostics market over a forecast period.
- High Cost
The huge expenditure required for setting up these techniques surely hamper the market growth. Several market players make huge investment in installing new and advanced machines to faster the process and in return the cost is increased.
This Europe respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Europe Respiratory Diagnostics Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
In the post-pandemic era, COVID-19 is expected to positively impact the ultr low freezers market, attributing to the increasing number of biobanks and plasma treatments.
Europe Respiratory Diagnostics Market Scope
The Europe respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Instruments and Devices
- Assays and Reagents
- Services and Software
Test Type
- Traditional Diagnostic Tests
- Mechanical Tests
- Imaging Tests
- Molecular Diagnostic Tests
Diseases
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung Cancer
- Asthma
- Tuberculosis
- Bronchitis
- Pulmonary Fibrosis
- Other Diseases
End User
- Hospital/Clinical Laboratories
- Physician Offices
- Reference Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Other
Europe Respiratory Diagnostics Market Regional Analysis/Insights
The Europe respiratory diagnostics market is analysed and market size insights and trends are provided by product and services, test type, diseases, end-user and distribution channel as referenced above.
The major countries covered in the respiratory diagnostics market report are the U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Germany's respiratory diagnostics market is expanding primarily as a result of increased focus on the high prevalence of disorders among the elderly. Rising social media concerns are also significant growth drivers for the market.
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和欧洲呼吸诊断市场份额分析
欧洲呼吸诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对欧洲呼吸诊断市场的关注有关
欧洲呼吸诊断市场的主要参与者包括:
- BD(美国)
- COSMED srl(意大利)
- 雅培(美国)
- 日本光电株式会社(日本)
- Drägerwerk AG & Co. KGaA(德国)
- Bio-Rad Laboratories, Inc.(美国)
- 赛默飞世尔科技公司(美国)
- 通用电气公司(美国)
- Koninklijke Philips NV(荷兰)
- 美敦力(美国)
- F. Hoffmann-La Roche Ltd(瑞士)
- MGC Diagnostics Corporation(美国)
- Masimo(美国)
- 生物梅里埃公司(法国)
- Carestream Health(美国)
- VYAIRE(美国)
- Seegene Inc.(韩国)
- ResMed(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.